Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Total Liabilities
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. total liabilities. Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has total liabilities worth TL120.48 Million TRY (≈ $2.70 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See ONCSM cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Total liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s total liabilities have evolved over time, based on quarterly financial data.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Total Liabilities
The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shareholder Value Beteiligungen AG
XETRA:SVE
|
Germany | €278.28K |
|
Sukhjit Starch & Chemicals Limited
NSE:SUKHJITS
|
India | Rs6.04 Billion |
|
Cenit Co. Ltd
KQ:037760
|
Korea | ₩124.74 Billion |
|
Geospace Technologies Corporation
NASDAQ:GEOS
|
USA | $31.58 Million |
|
Rapala VMC Oyj
HE:RAP1V
|
Finland | €165.60 Million |
|
TsannKuen (China) Enterprise Co. Ltd
SHE:200512
|
China | HK$938.16 Million |
|
Marygold Companies Inc
NYSE MKT:MGLD
|
USA | $5.11 Million |
|
Beforepay Group Ltd
AU:B4P
|
Australia | AU$35.83 Million |
Liability Composition Analysis (2020–2023)
This chart breaks down Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) total assets.
Liquidity & Leverage Metrics
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Total Liabilities Ratios Explained
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
The table below shows the annual total liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | TL106.61 Million ≈ $2.39 Million |
-15.06% |
| 2022-12-31 | TL125.50 Million ≈ $2.81 Million |
+147.27% |
| 2021-12-31 | TL50.75 Million ≈ $1.14 Million |
-9.55% |
| 2020-12-31 | TL56.11 Million ≈ $1.26 Million |
-- |
About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins,… Read more